Profitability
Weight: 15%
D-
32
- 5yr Avg ROIC -3.8%
- Operating Margin Trend +15.73 pp/yr
ACAD
ACADIA Pharmaceuticals Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
D-
28
- 5yr Avg ROE 2.8%
- 5yr Share-Count CAGR 1.7%
Growth Quality
Weight: 35%
A+
100
- 5yr Revenue CAGR 22.0%
- 5yr EPS CAGR 68.4%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
F
20
- 5yr FCF Margin -5.0%
- 5yr FCF/NI Conversion 0.48x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -5.53x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 6.04
Stability
Weight: 5%
A-
83
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 4
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 2 added; 2 trimmed.
- Holders
- 4
- Avg Δ position
- -1.8%
- New buys
- 0
- Full exits
- 0
- Greenblatt increased +119%
- Wood decreased -100%
- Cooperman decreased -29%